Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Witte

Showing results (61-70 of 204) with videos related to

Pageof 21
Sort By:
Acta Diabetologica|March 27, 2015
Impact of intensive treatment on serum methylglyoxal levels among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark studyTroels M Jensen, Dorte Vistisen, Thomas Fleming, et al.
Diabetologia|August 20, 2016
Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohortPia Deichgræber, Daniel R Witte, Holger J Møller, et al.
BMC Medical Genetics|February 14, 2012
The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individualsKarina Banasik, Mette Hollensted, Ehm Andersson, et al.
Diabetes Care|November 30, 2011
QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications studyGabriella Gruden, Sara Giunti, Federica Barutta, et al.
Diabetologia|May 25, 2019
Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort studyDorte Vistisen, Mika Kivimäki, Leigh Perreault, et al.
Diabetes Care|February 2, 2021
Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort StudyChristian S Hansen, Marit E Jørgensen, Marek Malik, et al.
Plos One|February 3, 2017
Does Training and Support of General Practitioners in Intensive Treatment of People with Screen-Detected Diabetes Improve Medication, Morbidity and Mortality in People with Clinically-Diagnosed Diabetes? Investigation of a Spill-Over Effect in a Cluster RCTMorten Charles, Mette V Skriver, Simon J Griffin, et al.
Diabetologia|December 6, 2017
Correction to: Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohortPia Deichgræber, Daniel R Witte, Holger J Møller, et al.
Journal of Epidemiology and Community Health|June 19, 2021
Effectiveness of the population-based 'check your health preventive programme' conducted in a primary care setting: a pragmatic randomised controlled trialAnne-Louise Bjerregaard, Else-Marie Dalsgaard, Niels-Henrik Bruun, et al.
Geroscience|April 19, 2023
Autonomic dysfunction is associated with the development of arterial stiffness: the Whitehall II cohortJonas R Schaarup, Martin S Christensen, Adam Hulman, et al.
Pageof 21

Showing results (61-70 of 204) with videos related to

Sort By:
Pageof 21
Acta Diabetologica|March 27, 2015
Impact of intensive treatment on serum methylglyoxal levels among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark studyTroels M Jensen, Dorte Vistisen, Thomas Fleming, et al.
Diabetologia|August 20, 2016
Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohortPia Deichgræber, Daniel R Witte, Holger J Møller, et al.
BMC Medical Genetics|February 14, 2012
The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individualsKarina Banasik, Mette Hollensted, Ehm Andersson, et al.
Diabetes Care|November 30, 2011
QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications studyGabriella Gruden, Sara Giunti, Federica Barutta, et al.
Diabetologia|May 25, 2019
Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort studyDorte Vistisen, Mika Kivimäki, Leigh Perreault, et al.
Diabetes Care|February 2, 2021
Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort StudyChristian S Hansen, Marit E Jørgensen, Marek Malik, et al.
Plos One|February 3, 2017
Does Training and Support of General Practitioners in Intensive Treatment of People with Screen-Detected Diabetes Improve Medication, Morbidity and Mortality in People with Clinically-Diagnosed Diabetes? Investigation of a Spill-Over Effect in a Cluster RCTMorten Charles, Mette V Skriver, Simon J Griffin, et al.
Diabetologia|December 6, 2017
Correction to: Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohortPia Deichgræber, Daniel R Witte, Holger J Møller, et al.
Journal of Epidemiology and Community Health|June 19, 2021
Effectiveness of the population-based 'check your health preventive programme' conducted in a primary care setting: a pragmatic randomised controlled trialAnne-Louise Bjerregaard, Else-Marie Dalsgaard, Niels-Henrik Bruun, et al.
Geroscience|April 19, 2023
Autonomic dysfunction is associated with the development of arterial stiffness: the Whitehall II cohortJonas R Schaarup, Martin S Christensen, Adam Hulman, et al.
Pageof 21